Krüppel-like factor 2 (KLF2) critically regulates activation and function of monocyte, which plays important pathogenic role in progressive joint destruction in rheumatoid arthritis (RA). It is yet to be established the molecular basis of KLF2-mediated regulation of monocytes in RA pathogenesis. Herein, we show that a class of compound, HDAC inhibitors (HDACi) induced KLF2 expression in monocytes both in vitro and in vivo. KLF2 level was also elevated in tissues, such as bone marrow, spleen and thymus in mice after infusion of HDACi. Importantly, HDACi significantly reduced osteoclastic differentiation of monocytes with the up-regulation of KLF2 and concomitant down-regulation of matrixmetalloproteinases both in the expression level as well as in the protein level. In addition, HDACi reduced K/BxN serum-induced arthritic inflammation and joint destruction in mice in a dose-dependent manner.
Krüppel-like transcription factor (KLF)s are involved in regulation of terminal differentiation of several immune cells. Lung KLF (LKLF) or KLF2 plays a significant regulatory role in haematopoietic cell biology including cell quiescence, cell proliferation, differentiation and survival. 9, 10 KLF2 also regulates myeloid cell activation and function. 11 During inflammation, KLF2 acts as a potent inhibitor of transcription factors like NF-κB and AP1, as well as of hypoxia-related HIF-1α protein. 12 Importantly, KLF2 is essential for embryonic erythropoiesis and KLF2-deficient mice are embryonic lethal because of the leaky blood vessels and haemorrhages. 13 Krüppel-like factor 2 is a negative regulator of monocyte activation and osteoclast differentiation, directs them towards quiescent state. 11, 14 The current study focuses on assessing role of a special class of pharmacological compounds, histone deacetylase inhibitors (HDACi) in modulation of KLF2 in monocytes both in vitro and in vivo. HDACi have been used clinically for the treatment of various cancer malignancies. 15 HDACs are well known for their role in chromatin remodelling, 16 and also regulate large number of non-histone proteins, which controls cell processes associated to various disease conditions. 17 Evidence show that HDACi controls NFκB-driven inflammatory responses through cell cycle arrest. 18 However, the effect of HDACi on inflammatory response varies according to the cell type and stimulus. As cell cycle arrest leads to cell quiescence, and KLF2 is induced upon cell quiescence, we were interested to know whether HDACi can mediate induction of KLF2. Among the common HDACi are suberoylanilide hydroxamic acid (SAHA), entinostat (SNDx-275 or MS-275) and Trichostatin A (TSA) are of consideration. In addition, it is yet to be defined how HDACi regulate myeloid KLF2 and RA pathogenesis.
To investigate the efficacy of HDACi against RA progression and to delineate the mechanistic evidence have driven us to explore this intrigued pathogenesis.
| MATERIALS AND METHODS

| Isolation and culture of monocytes from murine bone marrow
Bone marrow (BM) cells were isolated from the femurs of 6-to 8-week-old C57BL/6 mice, and cultured in DMEM medium (Sigma) supplemented with 10% foetal bovine serum (ThermoFisher, Grand
Island, NY, USA) at 37°C in a 5% CO 2 
| In vivo stimulation of mice with HDACi
To investigate whether systemic stimulation with HDACi to the mice have any effect on immune cell-rich tissues, three mice per group were injected intra peritoneal (ip) with MS275 (5 mg/kg BW in 50 μL DMSO) and TSA (10 mg/kg BW in 50 μL DMSO) or DMSO (50 μL, as a control). After 24 hours of HDACi injections, BM, spleen and thymus were harvested. A part of the tissues was homogenized and RNA was extracted, and another part was subjected to protein extraction.
| Isolation of human monocytes
Fresh human peripheral blood (n = 6) was collected with an approved IRB and written consent from donors from The Ohio State University Medical Center, Columbus, OH and processed following earlier described protocol. 11, 19 In, brief, peripheral blood mononuclear cells were isolated from freshly collected blood using FicollPaque density centrifugation. CD14 + cells were isolated by using an AutoMACS device, CD14 + antibody and reagents (all from Miltenyi Biotec, San Diego, CA, USA) following earlier established protocol. 11, 20 A part of the CD14 + cells was used for RNA extraction, and another part was subjected to protein extraction. 
| Real time RT-PCR analysis
| Histological assessment of arthritis
Arthritis was assessed by histological examination as described, 
| Western blotting
Total protein analysis was performed with the standard Western blot were washed and proteins were separated by SDS-PAGE as previously described 11 and developed with anti-Flag antibody (Sigma).
| KLF2 overexpression in RAW264.7 cells by adenoviral infection
RAW 264.7 cells were infected with control (Ad-GFP) or KLF2 (Ad-KLF2) virus at 50 MOI. In general,~40%-50% infection was achieved within 24-48 hours of incubation with adenovirus at which time cells were harvested and lysed for protein analysis.
| Statistical analysis
Values were expressed as mean ± SEM and statistical analysis was performed by ANOVA. Student's t test was performed and the results were considered significant when P-values were <0.05.
| RESULTS
| Effect of HDAC inhibitors on KLF2 expression in monocytes
To test the effect of HDACi on KLF2 gene expression, three different types of HDACi (MS275, SAHA and TSA) at various concentrations Figure 2C ). These data indicates that KLF2 level both in gene expression and protein was up-regulated in vivo in BM, spleen and thymus tissues after injection with HDACi either MS275 or TSA.
| Effect of HDAC inhibitor on osteoclastic differentiation of monocytes
We next sought to find whether HDAC inhibitors have any effect on monocyte differentiation to osteoclasts, as they are the important cells in arthritic tissue damages. 
| Factors associated with HDAC inhibitormediated osteoclastic differentiation
To further investigate the reasons for HDAC inhibitor-mediated reduced osteoclastic differentiation of monocytes, we analysed live cells in next sets of experiments. Real-time PCR data revealed that the expression of MMP3, 9 and 13 were significantly reduced in both RAW 264.7 ( Figure 4A ) and primary BM cells ( Figure 4B) Figure 4C ) and primary BM cells ( Figure 4D 
| Effect of HDAC inhibitors in K/BxN seruminduced arthritis in mice
As HDAC inhibitor induced KLF2 in monocytes and reduced osteoclastic differentiation of monocytes, we next tested whether HDAC inhibitor has any effect on arthritic inflammation and severity in joint destruction in mice. Mice were induced arthritis using K/BxN serum and treated with HDAC inhibitors (either SAHA, 10 mg/kg body weight; or SAHA 30 mg/kg body weight; or MS275, 5 mg/kg body weight) during the course of arthritis development for 7 days. Ankles were measured, and found that a significant reduction in inflammation after injection of HDAC inhibitor with SAHA 30 mg/kg body weight; or MS275, 5 mg/kg body weight from day 2 to day 7
( Figure 5A ). When the lower dose of SAHA (10 mg/kg body weight) was used as therapeutics, a marked reduction in ankle inflammation were also observed ( Figure 5A , left panel). These data show that ankle inflammation could be reduced after HDAC inhibitor therapy to K/BxN serum-induced mice.
| Effects of HDAC inhibitors on bone and cartilage damage upon K/BxN serum-induced arthritis
As HDAC inhibitor reduced ankle inflammation in K/BxN seruminduced arthritic mice, we next sought to find whether bone and cartilage damage were also reduced. H&E staining revealed that a reduced bone and cartilage damage after treatment with either of the HDAC inhibitors like SAHA or MS275 ( Figure 5B ). The damage of bone and cartilage were significantly lower in animals ( Figure 5C ) that were treated with SAHA (30 mg/kg body weight) or MS275
(5 mg/kg body weight). Out of many inflammatory signals, matrix-proteolytic enzymemediated signalling is highly responsible for destruction of cartilages, bones and articular structures. 32 MMPs can cleave adhesion molecules, cytokines, chemokines, growth factors, and their receptors and binding proteins. 33 Moreover, they also activate other proteases, and thus, mediate a cascade of severe matrix degradation process. 33 Several MMPs are elevated in the synovial fluid and in the serum of RA patients. 34 Herein, we show that reductions in osteoclastic differen- These data support HDACi's ability to exert anti-inflammatory effect on K/BxN serum-induced arthritic mice, which is in consistent with the earlier observations with different models. 35 Taken together, these data not only show the efficacy of HDACi against RA but also suggests a potential for future therapeutic modality against RA.
Finally, to determine whether KLF2 and HDAC interact each other in monocytes and mediate an effect on inflammatory transcriptional regulation process. Our data suggests that there is a clear interaction between HDACi and KLF2 in the transcriptional regulation level. We assume that acetylation of histone 3 proteins might play a key role in the HDACi regulated transcription progression, as we found the H3 acetylation is induced by HDACi. Histone acetylation causes alteration in nucleosomal conformation, 36 which can increase the accessibility of transcriptional regulatory proteins to chromatin templates. 37 Our earlier published data suggests that histone acetyla- 
